JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

JNJ

172.24

-0.77%↓

ABBV

197.9

+0.31%↑

AZN

74.9

+1.11%↑

NVS

119.11

+0.89%↑

ABT

129.76

-1.11%↓

Search

Phibro Animal Health Corp

Открыт

СекторЗдравоохранение

29.19 3.25

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

27.91

Макс.

29.31

Ключевые показатели

By Trading Economics

Доход

18M

21M

Продажи

39M

348M

P/E

Средняя по отрасли

34.795

34.393

Дивидендная доходность

1.84

Рентабельность продаж

6.003

Сотрудники

1,940

EBITDA

26M

51M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+0.7% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

1.84%

2.54%

Следующий отчет о доходах

27 авг. 2025 г.

Дата следующей выплаты дивидендов

24 сент. 2025 г.

Следующая эксдивидендная дата

3 сент. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

107M

1.1B

Предыдущая цена открытия

25.94

Предыдущая цена закрытия

29.19

Новостные настроения

By Acuity

36%

64%

115 / 374 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

Phibro Animal Health Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 авг. 2025 г., 17:49 UTC

Главные движущие силы рынка

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 авг. 2025 г., 17:18 UTC

Главные движущие силы рынка

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 авг. 2025 г., 16:25 UTC

Отчет

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 авг. 2025 г., 23:50 UTC

Обсуждения рынка

Nikkei May Rise as Yen Weakens -- Market Talk

11 авг. 2025 г., 23:42 UTC

Обсуждения рынка

Global Energy Roundup: Market Talk

11 авг. 2025 г., 23:42 UTC

Обсуждения рынка

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 авг. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 авг. 2025 г., 23:32 UTC

Обсуждения рынка

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 авг. 2025 г., 23:02 UTC

Обсуждения рынка

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 авг. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement 2Q Rev $25.8M >EXOD

11 авг. 2025 г., 20:14 UTC

Обсуждения рынка

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 авг. 2025 г., 19:12 UTC

Обсуждения рынка

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 авг. 2025 г., 18:56 UTC

Обсуждения рынка

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 авг. 2025 г., 18:31 UTC

Обсуждения рынка

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 авг. 2025 г., 17:43 UTC

Обсуждения рынка

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 авг. 2025 г., 17:28 UTC

Обсуждения рынка

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 авг. 2025 г., 17:16 UTC

Обсуждения рынка

Commodity Longs Fall to 11-Month Low -- Market Talk

11 авг. 2025 г., 16:42 UTC

Приобретения, слияния, поглощения

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 авг. 2025 г., 16:27 UTC

Приобретения, слияния, поглощения

BBVA Says Sabadell Offer Remains in Effect

11 авг. 2025 г., 16:26 UTC

Приобретения, слияния, поглощения

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 авг. 2025 г., 16:25 UTC

Приобретения, слияния, поглощения

Banco de Sabadell Announced TSB Sale on July 1

11 авг. 2025 г., 16:25 UTC

Приобретения, слияния, поглощения

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Сравнение c конкурентами

Изменение цены

Phibro Animal Health Corp Прогноз

Целевая цена

By TipRanks

0.7% рост

Прогноз на 12 месяцев

Средняя 28.75 USD  0.7%

Максимум 35 USD

Минимум 24 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Phibro Animal Health Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

4 ratings

1

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

17 / N/AПоддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Weak Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

115 / 374Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.